SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

NextNRG Faces Nasdaq Delisting; Trading Suspension Set for November 12

NextNRG says Nasdaq determined to delist its shares, with trading set to be suspended at market open on November 12, 2026.

NXXT
SquawkNews Desk 1 updates Updated Nov 11, 2026, 08:51 PM UTC

Story updates

08:51:47 PM UTC
SquawkNews
Company has submitted a request for reconsideration and intends to seek Listing Council review; common stock expected to be quoted on the OTC Markets under the symbol “NXXT"MIAMI, FL, Nov. 11, 2026 (GLOBE NEWSWIRE) -- NextNRG, Inc. NASDAQ:NXXT (“NextNRG” or the “Company”), a pioneer in AI-driven en…

Related stories

Blackstone, Pfizer Partner to Fund Obesity Drug Development Blackstone will provide up to $1.5 billion to fund Pfizer’s obesity drug development. M impact | EQUITY | Nov 11, 2026, 09:43 PM UTC Aristocrat Leisure Raises Annual Dividend; CEO to Retire in April Aristocrat Leisure says CEO Trevor Croker intends to retire in April and names Dafne Guisard as incoming CEO. The company also raises its annual dividend. M impact | EQUITY | Nov 11, 2026, 09:43 PM UTC CAE Q2 Revenue Misses Estimates; FY Adjusted EPS Outlook Raised Canada's CAE reported Q2 revenue below estimates and raised its full-year adjusted EPS outlook. M impact | EQUITY | Nov 11, 2026, 09:41 PM UTC Nasdaq Panel Determines to Delist NextNRG Stock NextNRG said a Nasdaq Hearings Panel determined to delist its stock. M impact | EQUITY | Nov 11, 2026, 09:38 PM UTC Pfizer secures up to $1.5 billion from Blackstone for obesity drug development M impact | EQUITY | Nov 11, 2026, 09:38 PM UTC Eneva Board Approves Up to R$ 1.6 Billion in Financing for Two Power Plants M impact | EQUITY | Nov 11, 2026, 09:38 PM UTC